{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:05:47Z","timestamp":1768453547488,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Cohort Construction Program of Peking University Third Hospital","award":["BYSYDL2023001"],"award-info":[{"award-number":["BYSYDL2023001"]}]},{"name":"Beijing Key Clinical Specialty Construction, General Program of National Natural Science Foundation of China","award":["82072870"],"award-info":[{"award-number":["82072870"]}]},{"name":"Youth Program of National Natural Science Foundation of China","award":["81901570"],"award-info":[{"award-number":["81901570"]}]},{"name":"Youth Program of National Natural Science Foundation of China","award":["82303801"],"award-info":[{"award-number":["82303801"]}]},{"name":"Innovation and Transformation Fund of Peking University Third Hospital","award":["BYSYZHKC2022110"],"award-info":[{"award-number":["BYSYZHKC2022110"]}]},{"name":"Peking University Third Hospital Clinical Key Project","award":["BYSY2022069"],"award-info":[{"award-number":["BYSY2022069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06756-0","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:46:44Z","timestamp":1751543204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of senescent CD4+ T cells in breakthrough infection of the new variant strain of SARS-CoV-2 in elderly patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhaoyuan","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongnan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-6431","authenticated-orcid":false,"given":"Jianling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"6756_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, china: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"6756_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21:361\u201379.","journal-title":"Nat Rev Microbiol"},{"key":"6756_CR3","doi-asserted-by":"publisher","first-page":"2249121","DOI":"10.1080\/22221751.2023.2249121","volume":"12","author":"H Wang","year":"2023","unstructured":"Wang H, Xue Q, Zhang H, Yuan G, Wang X, Sheng K, Li C, Cai J, Sun Y, Zhao J, et al. Neutralization against Omicron subvariants after BA.5\/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination(1). Emerg Microbes Infect. 2023;12:2249121.","journal-title":"Emerg Microbes Infect"},{"key":"6756_CR4","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1038\/s41467-024-51973-8","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Guo H, Wang A, Cao L, Fan Q, Jiang J, Wang M, Lin L, Ge X, Wang H, et al. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants. Nat Commun. 2024;15:7715.","journal-title":"Nat Commun"},{"key":"6756_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","volume":"15","author":"D Planas","year":"2024","unstructured":"Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, Porrot F, Guivel-Benhassine F, Jeyarajah B, Brisebarre A, et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat Commun. 2024;15:2254.","journal-title":"Nat Commun"},{"key":"6756_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-023-06750-w","volume":"624","author":"Q Wang","year":"2023","unstructured":"Wang Q, Guo Y, Liu L, Schwanz LT, Li Z, Nair MS, Ho J, Zhang RM, Iketani S, Yu J, et al. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 Spike. Nature. 2023;624:639\u201344.","journal-title":"Nature"},{"key":"6756_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41591-023-02212-y","volume":"29","author":"K Leung","year":"2023","unstructured":"Leung K, Lau E, Wong C, Leung GM, Wu JT. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022. Nat Med. 2023;29:579\u201382.","journal-title":"Nat Med"},{"key":"6756_CR8","doi-asserted-by":"publisher","first-page":"1083523","DOI":"10.3389\/fimmu.2023.1083523","volume":"14","author":"A Simayi","year":"2023","unstructured":"Simayi A, Li C, Chen C, Wang Y, Dong C, Tian H, Kong X, Zhou L, Peng J, Zhang S, et al. Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: role in inferring the history and duration of infection. Front Immunol. 2023;14:1083523.","journal-title":"Front Immunol"},{"key":"6756_CR9","first-page":"CD015477","volume":"12","author":"C Grana","year":"2022","unstructured":"Grana C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, Buckley BS, Probyn K, Villanueva G, Henschke N, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12:CD015477.","journal-title":"Cochrane Database Syst Rev"},{"key":"6756_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0140-6736(22)00011-3","volume":"399","author":"A Rearte","year":"2022","unstructured":"Rearte A, Castelli JM, Rearte R, Fuentes N, Pennini V, Pesce M, Barbeira PB, Iummato LE, Laurora M, Bartolomeu ML, et al. Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in argentina: a test-negative, case-control, and retrospective longitudinal study. Lancet. 2022;399:1254\u201364.","journal-title":"Lancet"},{"key":"6756_CR11","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.1038\/s41467-022-34400-8","volume":"13","author":"B Ju","year":"2022","unstructured":"Ju B, Fan Q, Wang M, Liao X, Guo H, Wang H, Ge X, Liu L, Zhang Z. Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4\/5\/2.75 subvariants in BA.2 breakthrough infections. Nat Commun. 2022;13:7120.","journal-title":"Nat Commun"},{"key":"6756_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41422-023-00781-8","volume":"33","author":"B Gao","year":"2023","unstructured":"Gao B, He L, Bao Y, Chen Y, Lu G, Zhang Y, Xu Y, Su B, Xu J, Wang Y, Yeap LS. Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection. Cell Res. 2023;33:258\u201361.","journal-title":"Cell Res"},{"key":"6756_CR13","unstructured":"Zhang J, Chang C, Liang Z, Hu T, Yin Z, Liang Y, Zhang T, Ding Y, Li X, Gai X, et al. Elevated CD4(+) T cell senescence associates with impaired immune responsiveness in severe COVID-19. Aging Dis. 2024;16:498\u2013511."},{"key":"6756_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jgs.16472","volume":"68","author":"Z Shahid","year":"2020","unstructured":"Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, Aggarwal CS, Vunnam R, Sahu N, Bhatt D, et al. COVID-19 and older adults: what we know. J Am Geriatr Soc. 2020;68:926\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"6756_CR15","doi-asserted-by":"publisher","first-page":"eabn8014","DOI":"10.1126\/sciimmunol.abn8014","volume":"7","author":"TA Bates","year":"2022","unstructured":"Bates TA, McBride SK, Leier HC, Guzman G, Lyski ZL, Schoen D, Winders B, Lee JY, Lee DX, Messer WB, et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci Immunol. 2022;7:eabn8014.","journal-title":"Sci Immunol"},{"key":"6756_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jinf.2022.01.012","volume":"84","author":"AA Mensah","year":"2022","unstructured":"Mensah AA, Lacy J, Stowe J, Seghezzo G, Sachdeva R, Simmons R, Bukasa A, O\u2019Boyle S, Andrews N, Ramsay M, et al. Disease severity during SARS-COV-2 reinfection: a nationwide study. J Infect. 2022;84:542\u201350.","journal-title":"J Infect"},{"key":"6756_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.amjms.2021.02.003","volume":"362","author":"D Hunsinger","year":"2021","unstructured":"Hunsinger D, Kutti SD, Rokkam D, Fantry D. COVID-19 reinfection in an immunosuppressed patient without an antibody response. Am J Med Sci. 2021;362:103.","journal-title":"Am J Med Sci"},{"key":"6756_CR18","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","volume":"28","author":"B Bowe","year":"2022","unstructured":"Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398\u2013405.","journal-title":"Nat Med"},{"key":"6756_CR19","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/j.ymthe.2022.04.014","volume":"30","author":"S McCafferty","year":"2022","unstructured":"McCafferty S, Haque A, Vandierendonck A, Weidensee B, Plovyt M, Stuchlikova M, Francois N, Valembois S, Heyndrickx L, Michiels J, et al. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity. Mol Ther. 2022;30:2968\u201383.","journal-title":"Mol Ther"},{"key":"6756_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vetimm.2017.02.002","volume":"186","author":"MC Rahe","year":"2017","unstructured":"Rahe MC, Murtaugh MP. Effector mechanisms of humoral immunity to porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol. 2017;186:15\u20138.","journal-title":"Vet Immunol Immunopathol"},{"key":"6756_CR21","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/infdis\/jix173","volume":"215","author":"AS Monto","year":"2017","unstructured":"Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. J Infect Dis. 2017;215:1782\u20138.","journal-title":"J Infect Dis"},{"key":"6756_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23:186\u201393.","journal-title":"Nat Immunol"},{"key":"6756_CR23","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Mateus J, Coelho CH, Dan JM, Moderbacher CR, Galvez RI, Cortes FH, Grifoni A, Tarke A, Chang J, et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185:2434\u201351.","journal-title":"Cell"},{"key":"6756_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2337\/db17-1218","volume":"68","author":"YH Lee","year":"2019","unstructured":"Lee YH, Kim SR, Han DH, Yu HT, Han YD, Kim JH, Kim SH, Lee CJ, Min BH, Kim DH, et al. Senescent T cells predict the development of hyperglycemia in humans. Diabetes. 2019;68:156\u201362.","journal-title":"Diabetes"},{"key":"6756_CR25","doi-asserted-by":"publisher","first-page":"eadg1094","DOI":"10.1126\/sciimmunol.adg1094","volume":"9","author":"SA Minnie","year":"2024","unstructured":"Minnie SA, Waltner OG, Zhang P, Takahashi S, Nemychenkov NS, Ensbey KS, Schmidt CR, Legg S, Comstock M, Boiko JR, et al. TIM-3(+) CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Sci Immunol. 2024;9:eadg1094.","journal-title":"Sci Immunol"},{"key":"6756_CR26","first-page":"e140","volume":"168","author":"F Limongi","year":"2017","unstructured":"Limongi F, Fallahi P. Hypersensitivity pneumonitis and alpha-chemokines. Clin Ter. 2017;168:e140\u20135.","journal-title":"Clin Ter"},{"key":"6756_CR27","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1080\/22221751.2022.2122581","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Wang H, Ai J, Shen L, Lin K, Yuan G, Sheng X, Jin X, Deng Z, Xu J, et al. Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: a multi-centre cohort study. Emerg Microbes Infect. 2022;11:2501\u20139.","journal-title":"Emerg Microbes Infect"},{"key":"6756_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41421-022-00472-5","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Ai J, Li X, Zhao X, Wu J, Zhang H, He X, Zhao C, Qiao R, Li M, et al. Neutralization of Omicron BA.4\/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera. Cell Discov. 2022;8:110.","journal-title":"Cell Discov"},{"key":"6756_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41392-022-01305-3","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li R, Li Y, Yang H, Zhou L, Yuan J, Pan T, Liu B, Zhang H, He Y. Antibody response and cross-neutralization after Omicron BA.2 infection. Signal Transduct Target Ther. 2023;8:25.","journal-title":"Signal Transduct Target Ther"},{"key":"6756_CR30","doi-asserted-by":"publisher","first-page":"100739","DOI":"10.1016\/j.xcrm.2022.100739","volume":"3","author":"H Parry","year":"2022","unstructured":"Parry H, Bruton R, Ayodele R, Sylla P, McIlroy G, Logan N, Scott S, Nicol S, Verma K, Stephens C, et al. Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. Cell Rep Med. 2022;3:100739.","journal-title":"Cell Rep Med"},{"key":"6756_CR31","doi-asserted-by":"crossref","unstructured":"Segato I, Mele D, Forlani G, Dalla GD, Mondelli MU, Varchetta S. T cell responses to BA.2.86 and JN.1 SARS-CoV-2 variants in elderly subjects. Vaccines (Basel). 2024;12.","DOI":"10.3390\/vaccines12121451"},{"key":"6756_CR32","doi-asserted-by":"publisher","first-page":"e202451142","DOI":"10.1002\/eji.202451142","volume":"55","author":"L Yong","year":"2025","unstructured":"Yong L, Hutchings C, Barnes E, Klenerman P, Provine NM. Distinct requirements for CD4(+) T cell help for immune responses induced by mRNA and adenovirus-vector SARS-CoV-2 vaccines. Eur J Immunol. 2025;55:e202451142.","journal-title":"Eur J Immunol"},{"key":"6756_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","volume":"3","author":"N Jo","year":"2023","unstructured":"Jo N, Hidaka Y, Kikuchi O, Fukahori M, Sawada T, Aoki M, Yamamoto M, Nagao M, Morita S, Nakajima TE, et al. Impaired CD4(+) T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination. Nat Aging. 2023;3:82\u201392.","journal-title":"Nat Aging"},{"key":"6756_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni.3665","volume":"18","author":"A Lanna","year":"2017","unstructured":"Lanna A, Gomes DC, Muller-Durovic B, McDonnell T, Escors D, Gilroy DW, Lee JH, Karin M, Akbar AN. A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging. Nat Immunol. 2017;18:354\u201363.","journal-title":"Nat Immunol"},{"key":"6756_CR35","doi-asserted-by":"publisher","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","volume":"6","author":"JB Mannick","year":"2014","unstructured":"Mannick JB, Del GG, Lattanzi M, Valiante NM, Praestgaard J, Huang B, Lonetto MA, Maecker HT, Kovarik J, Carson S, et al. mTOR Inhibition improves immune function in the elderly. Sci Transl Med. 2014;6:268ra179.","journal-title":"Sci Transl Med"},{"key":"6756_CR36","doi-asserted-by":"crossref","unstructured":"Mannick JB, Morris M, Hockey HP, Roma G, Beibel M, Kulmatycki K, Watkins M, Shavlakadze T, Zhou W, Quinn D et al. TORC1 Inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018;10.","DOI":"10.1126\/scitranslmed.aaq1564"},{"key":"6756_CR37","doi-asserted-by":"publisher","first-page":"eadi9379","DOI":"10.1126\/sciadv.adi9379","volume":"10","author":"BA Krishna","year":"2024","unstructured":"Krishna BA, Lim EY, Metaxaki M, Jackson S, Mactavous L, Lyons PA, Doffinger R, Bradley JR, Smith K, Sinclair J, et al. Spontaneous, persistent, T cell-dependent IFN-gamma release in patients who progress to long Covid. Sci Adv. 2024;10:eadi9379.","journal-title":"Sci Adv"},{"key":"6756_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-024-01846-9","volume":"9","author":"HH Liu","year":"2024","unstructured":"Liu HH, Xie Y, Yang BP, Wen HY, Yang PH, Lu JE, Liu Y, Chen X, Qu MM, Zhang Y, et al. Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study. Signal Transduct Target Ther. 2024;9:129.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06756-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:46:48Z","timestamp":1751543208000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6756"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06756-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study\u2019s sampling and experimental steps were approved by the Ethics Committee of Peking University Third Hospital (License No. IRB00006761-M2022865).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants (or their legal guardians) provided explicit consent for the anonymized publication of research data. And written informed consent for research participation was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"737"}}